It has only been a week since we have viewed the positive videos...

It has only been a week since we have viewed the positive videos with LC and YF, speaking about further advances in our trials and already any enthusiasm has waned.
Some of this has been due to fear of competition getting in before us with similar or better treatment, and yet neither Leslie or Yuman ever speak of any concern when it comes to competition.
In fact they both say how healthy this is in the development of a cure for cancer.
We have been told that Azer-cel will be just as, if not more effective in tackling Myalomas and other blood cancers, data from the Phase 1 trial show this.
It is off the shelf, with healthy donors and quicker to treat patients.
OnCARlytics as Leslie has often said could be a paradigm shift in the treatment of solid cancer, remembering this is 90% of the cancer market.
Even if we are not the first, or the fifth one to get to market with this as long as it is safe, and more importantly effective in treating any solid tumours we would be assured of a share of this huge market.
It is time for calm, it is time to go back and look at why you first bought into this company, if you find seeds of doubt looking too large maybe it is time to move on.

DYOR opinion only